首页> 外文期刊>World Journal of Surgical Oncology >Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer
【24h】

Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer

机译:microRNA(miRNA)表达谱分析发现11种与非小细胞肺癌相关的关键生物标志物

获取原文
           

摘要

Background Non-small cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases which cause most of cancer-related deaths globally. However, the results vary largely in different studies due to different platforms and sample sizes. Here, we aim to identify the key miRNAs in the carcinogenesis of NSCLC that might be potential biomarkers for this cancer. Methods Meta-analysis was performed on miRNA profile using seven datasets of NSCLC studies. Furthermore, we predicted and investigated the functions of genes regulated by key miRNAs. Results Eleven key miRNAs were identified, including 2 significantly upregulated ones (hsa-miR-21-5p and hsa-miR-233-3p) and 9 downregulated ones (hsa-miR-126-3p, hsa-miR-133a-3p, hsa-miR-140-5p, hsa-miR-143-5p, hsa-miR-145-5p, hsa-miR-30a-5p, hsa-miR-30d-3p, hsa-miR-328-3pn, and hsa-miR-451). The functional enrichment analysis revealed that both up- and downregulated miRNAs were proportionally associated with regulation of transcription from RNA polymerase II promoter. According to transcription factor analysis, there were 65 (43.9%) transcription factors influenced by both up- and downregulated miRNAs. Conclusions In this study, 11 meta-signature miRNAs, as well as their target genes and transcription factors, were found to play significant role in carcinogenesis of NSCLC. These target genes identified in our study may be profitable to diagnosis and prognostic prediction of NSCLC as biomarkers.
机译:背景非小细胞肺癌(NSCLC)占全球导致大多数与癌症相关死亡的肺癌病例的85%以上。但是,由于平台和样本量的不同,不同研究的结果差异很大。在这里,我们旨在鉴定NSCLC癌变过程中的关键miRNA,这些miRNA可能是该癌症的潜在生物标记。方法使用七个非小细胞肺癌研究数据集对miRNA谱进行荟萃分析。此外,我们预测并研究了由关键miRNA调控的基因的功能。结果鉴定出11个关键的miRNA,包括2个显着上调的基因(hsa-miR-21-5p和hsa-miR-233-3p)和9个下调的基因(hsa-miR-126-3p,hsa-miR-133a-3p, hsa-miR-140-5p,hsa-miR-143-5p,hsa-miR-145-5p,hsa-miR-30a-5p,hsa-miR-30d-3p,hsa-miR-328-3pn和hsa -miR-451)。功能富集分析显示,上调和下调的miRNA均与RNA聚合酶II启动子转录的调节成比例相关。根据转录因子分析,有65个(43.9%)转录因子受上调和下调的miRNA的影响。结论在这项研究中,发现11种元签名的miRNA及其靶基因和转录因子在NSCLC的癌变过程中起重要作用。在我们的研究中鉴定出的这些靶基因可能对诊断和预后预测NSCLC作为生物标志物有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号